(Press-News.org) SAN ANTONIO — Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to researchers from the University of Texas MD Anderson Cancer Center.
Patients with CTCs in their blood before chemotherapy treatment had reduced survival and those with these cells in their blood after the stem cell transplant recurred faster and died earlier. These findings were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec 8-12.
While it has been known that CTCs in metastatic breast cancer are linked to cancer recurrence and lower survival, this study adds several new insights, the researchers said. One is that the process of collecting hematopoietic progenitor cells appears to recruit CTCs from bone marrow into the blood, and the other is that these CTCs are likely to be responsible for cancer recurrence.
"Our group had previously shown that metastatic breast cancer patients with CTCs in their blood relapsed faster and now we see that these same cells can be recruited from bone marrow and that they may have the same effect on disease outcome," said the lead researcher Hui Gao, Ph.D., a research scientist working in the laboratory of James M. Reuben, Ph.D.
"Furthermore, some CTCs seem to have the characteristic markings of stem-like cells, but we don't know yet if they are cancer stem cells," Gao said.
The 21 patients included in this study were younger women (average age of 44) diagnosed with metastatic breast cancer who were offered high-dose chemotherapy followed by stem cell transplant. Before chemotherapy, patients were given a growth factor treatment to recruit hematopoietic progenitor cells from bone marrow, then the cells were harvested from their blood.
CTCs were found in six patients before transplant and in nine patients one month after. Researchers determined that more than five CTCs at baseline was associated with shorter overall survival and that five or more CTCs after transplant was linked to both shorter relapse-free survival and overall survival.
The process of using growth factors to mobilize hematopoietic stem cells also appears to mobilize some CTCs that have lost their epithelial properties and undergo mesenchymal transition, according to the researchers. Such cells are not easily detected by the conventional CTC detection assays and the importance of this observation might be overlooked by the clinicians.
High-dose chemotherapy followed by stem cell transplant did reduce the number of existing CTCs in some patients, but increased CTCs in other patients. Patients who recurred faster and had shorter survival had a higher percentage of epithelial cells with stem-like markings mixed in with blood hematopietic progenitor cells that were mobilized by the growth factor to enter blood stream.
"When we enriched for hematopoietic progenitor cells, we found some CTCs within the milieu of cells we collected," Gao said.
In some cases, mobilization may have facilitated the release of cancer stem cells from the bone marrow that were associated with shorter relapse-free survival. However, mobilized CTCs can be removed from the final transplanted product using a procedure to positively select for CD34+ hematopoietic progenitor cells. This procedure may account for the fact that the patients with low CTCs did well.
###
Follow the AACR on Twitter @AACR, and throughout the meeting using the hash tag #SABCS.
Recordings of the teleconferences and video interviews with researchers will posted to the AACR website throughout the meeting: http://www.aacr.org/page23506.aspx.
The mission of the CTRC-AACR San Antonio Breast Cancer Symposium is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for breast cancer patients. The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the American Association for Cancer Research (AACR) and Baylor College of Medicine are joint sponsors of the San Antonio Breast Cancer Symposium. This collaboration utilizes the clinical strengths of the CTRC and Baylor, and the AACR's scientific prestige in basic, translational and clinical cancer research to expedite the delivery of the latest scientific advances to the clinic. The 33rd annual symposium is expected to draw nearly 9,000 participants from more than 90 countries.
CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer
2010-12-11
ELSE PRESS RELEASES FROM THIS DATE:
Phase III efficacy data on bevacizumab plus chemotherapy in early breast cancer to be presented
2010-12-11
SAN ANTONIO — Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Gunter von Minckwitz, M.D., Ph.D., managing director of the German Breast Group, and colleagues are conducting final analyses on efficacy data from this study, which will detail the early treatment of more than 1,900 patients with HER2-negative breast cancer treated with chemotherapy with or without bevacizumab.
"So far, ...
FReD can help explain how a bee sees!
2010-12-11
Bees can see colours but they perceive the world differently to us, including variations in hue that we cannot ourselves distinguish.
Researchers at Queen Mary, University of London and Imperial College London have developed FReD – the Floral Reflectance Database – which holds data on what colours flowers appear to be, to bees. The development of the catalogue, which has involved a collaborative effort between researchers at two Schools at Queen Mary is reported in the journal PLoS ONE.
The work addresses the existing issue that records of flower colours do not take ...
Boxing -- bad for the brain
2010-12-11
Up to 20% of professional boxers develop neuropsychiatric sequelae. But which acute complications and which late sequelae can boxers expect throughout the course of their career? These are the questions studied by Hans Förstl from the Technical University Munich and his co-authors in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[47]: 835-9).
Their evaluation of the biggest studies on the subject of boxers' health in the past 10 years yielded the following results: The most relevant acute consequence is the knock-out, which conforms ...
Wind and water have shaped Schiaparelli on Mars
2010-12-11
The small crater embedded in the northwestern rim of the Schiaparelli impact basin features prominently in this new image from ESA's Mars Express. All around is evidence for past water and the great martian winds that periodically blow.
Schiaparelli is a large impact basin about 460 km in diameter located in the eastern Terra Meridiani region of the equator of Mars. The centre of the basin lies at about 3°S/17°E and is named after the Italian astronomer Giovanni Schiaparelli (1835�). Although he also studied Mercury and Venus, he is best known for his observations ...
Beyond bars
2010-12-11
Despite threats of violence, imprisonment and death, writers around the world continue to fight to make their voices heard. The latest issue of Index on Censorship pays tribute to one of the world's longest running campaigns for free expression, English PEN's Writers in Prison Committee (WiPC). Founded in 1960, the WiPC supports and protects writers facing persecution around the globe. Contributors to Beyond Bars – including award-winning authors Margaret Atwood, Sir Tom Stoppard and William Boyd – highlight the vital role writers can play in supporting their colleagues. ...
Assessing the seismic hazard of the central eastern United States
2010-12-11
As the U.S. policy makers renew emphasis on the use of nuclear energy in their efforts to reduce the country's oil dependence, other factors come into play. One concern of paramount importance is the seismic hazard at the site where nuclear reactors are located.
Russell A. Green, associate professor of civil and environmental engineering at Virginia Tech, spent five years as an earthquake engineer for the U.S. Defense Nuclear Facilities Safety Board in Washington, D.C., prior to becoming a university professor. Part of his responsibility at the safety board was to perform ...
Iron legacy leaves soil high in manganese
2010-12-11
Iron furnaces that once dotted central Pennsylvania may have left a legacy of manganese enriched soils, according to Penn State geoscientists. This manganese can be toxic to trees, especially sugar maples, and other vegetation.
The research, which quantified the amounts of manganese in soil core samples, was part of work done at the Shale Hills Critical Zone Observatory funded by the National Science Foundation.
"Our group's focus was to study the soil chemistry," said Elizabeth M. Herndon, graduate student in geosciences. "We saw excess manganese in the soil and ...
Twin study helps scientists link relationship among ADHD, reading, math
2010-12-11
Children with ADHD can sometimes have more difficulties on math and reading tests compared to their peers. A new study published in Psychological Science, a journal of the Association for Psychological Science, used identical and fraternal twins to look at the genetic and environmental influences underlying ADHD behaviors, reading, and math skills in children in an attempt to better understand the relationship among them.
Sara Hart, of the Florida State University, and her colleagues used twins enrolled in a long-term study of reading and math. Hart says by focusing ...
EARTH: Trade imbalance, America exports emissions to China
2010-12-11
Alexandria, VA – America has made great strides in recent years to reduce carbon emissions by increasing efficiency and turning to other, low or non-carbon energy sources. Meanwhile, carbon emissions in China have grown dramatically during that same time. EARTH looks at this disparity and asks the difficult questions about who is to blame when the coal China is burning is imported from "cleaner" countries and the emissions are produced to manufacture goods exported back to places with lower emissions.
Learn more about this eye-opening subject in January's featured article ...
Drugs are safe, active in patients normally ineligible for clinical trial
2010-12-11
ORLANDO - A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance status - a measure of disease progression - researchers reported this week at the 52nd American Society of Hematology Annual Meeting.
"Our findings suggest current eligibility standards that prevent participation by these patients in phase I and phase II clinical trials might be inadequate," said Guillermo Garcia-Manero, M.D., professor in ...